Young David (CIK 1378166) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy PCSA (2,531 shares), Buy PCSA (2,067 shares), Buy PCSA (1,786 shares), Buy PCSA (1,545 shares), Buy PCSA (1,706 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 2,531 | $4,885 |
| 2026-06-16 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 2,067 | $4,589 |
| 2026-06-01 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 1,786 | $4,590 |
| 2026-05-19 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 1,545 | $4,589 |
| 2026-05-01 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 1,706 | $4,589 |
| 2026-04-17 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 1,545 | $4,589 |
| 2026-02-04 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 49 | $0 |
| 2025-04-11 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 17,272 | $0 |
| 2025-04-11 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Sell | 5,345 | $2,191 |
| 2025-01-29 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | Buy | 124,500 | $0 |
Source: SEC Form 4 filings · as of 2026-07-01